Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2005
11/02/2005EP1590362A1 Improved method for bisulfite treatment
11/02/2005EP1590361A2 Process for purifying oligonucleotide synthons
11/02/2005EP1589931A2 RNAi TARGETING OF VIRUSES
11/02/2005EP0923595B1 Nucleic acid mediated electron transfer
11/02/2005CN1692157A DNA nanocage by self-organization of DNA and process for producing the same, and DNA nanotube and molecule carrier using the same
11/02/2005CN1692121A A full-length polynucleotide sequence coding chicken type II collagen and the use of it
11/01/2005US6960656 RNA encodes a novel sub-class of immunoglobulin superfamily with highest homologies to neural cell adhesion molecules Down Syndrome-Cell Adhesion Molecule (DS-CAM)
11/01/2005US6960471 For cancer diagnostics
11/01/2005US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic
10/2005
10/27/2005WO2005101196A2 Integrated configuration system for use in a process plant
10/27/2005WO2005100586A2 Method for construction and use of kluyveromyces lactis promoter variants in k.lactis that substantially lack e. coli transcriptional capability
10/27/2005WO2005100568A1 Recombined dna, pasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/27/2005WO2005100565A1 Novel fluorescent protein and gene coding for the same
10/27/2005WO2005100544A2 SMALL RNAs AND BACTERIAL STRAINS INVOLVED IN QUORUM SENSING
10/27/2005WO2005100447A1 Peg-functional nucleic acid conjugate
10/27/2005WO2005100375A1 Process for the removal of exocyclic base protecting groups
10/27/2005WO2005099770A2 Pancreatic islet microrna and methods for inhibiting same
10/27/2005WO2005060642A3 Rationally designed antibodies
10/27/2005WO2005060375A3 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2005012531A3 Antibody cdr polypeptide sequences with restricted diversity
10/27/2005WO2005007871B1 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof
10/27/2005WO2005007825A3 Modulation of aminopeptidase n expression
10/27/2005WO2004076629A3 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES
10/27/2005WO2004064760A3 Aptamer therapeutics useful in ocular pharmacotherapy
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050241024 Transgenic plant-based vaccines
10/27/2005US20050241016 Plant centromere compositions
10/27/2005US20050241015 Glycine max plant cell with minichromosome that is not integrated into genome and comprises centromere sequence which confers ability to segregate to daughter cells and at least 5 repeated nucleotide sequences; genetic engineering
10/27/2005US20050241010 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer' s disease
10/27/2005US20050241006 Human antibodies derived from immunized xenomice
10/27/2005US20050240015 Solution phase synthesis of oligonucleotides
10/27/2005US20050240014 Connective tissue growth factor homologs
10/27/2005US20050239739 Conjugates and compositions for cellular delivery
10/27/2005US20050239737 Identification of molecular interaction sites in RNA for novel drug discovery
10/27/2005US20050239736 Composition for treating an immune system deficiency comprising vaccine and an oligonucleotide delivery complex having an immunostimulatory dinucleotide associated with lipid or sterol; antisense therapies; gene expression inhibition; viricides
10/27/2005US20050239734 C-class oligonucleotide analogs with enhanced immunostimulatory potency
10/27/2005US20050239733 Sequence requirements for inhibitory oligonucleotides
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239731 chemically synthesized double stranded siNA against p38 RNA; use against diseases such as cancer, inflammatory, autoimmune, and/or proliferative disorders
10/27/2005US20050239729 Incorporating the pro-apoptotic protein BAX and autoantigens adenoviral protein E3-GP19k and Delta BCL-2 into an injectable antidiabetic or hypoglycemic formulation; prevention, diagnosis and monitoring of diabetic patients
10/27/2005US20050239728 Double stranded rna structures and constructs, and methods for generating and using the same
10/27/2005US20050239702 Methods of modulating FabH activity
10/27/2005US20050239172 Methods and DNA constructs for high yield production of polypeptides
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239168 Detecting moderators of kinase peptide; encoding genes
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239130 Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
10/27/2005US20050239126 Proteases
10/27/2005US20050239124 Modulation of STAT 6 expression
10/27/2005US20050239121 Non-aggregating non-quenching oligomers comprising nucleotide analogs; methods of synthesis and use thereof
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239100 Using primer specific replication to microorganism polynucleotides; gene expression analysis; genomics; disease diagnosis
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239094 Compositions and methods for inducing and regulating bone formation
10/27/2005US20050239093 Toll-like receptor
10/27/2005US20050239088 Intron fusion proteins, and methods of identifying and using same
10/27/2005US20050239082 Alien sequences
10/27/2005US20050239081 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying
10/27/2005US20050239078 Sequence tag microarray and method for detection of multiple proteins through DNA methods
10/27/2005US20050239073 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof
10/27/2005US20050239065 Formed by splicing, genetic deletions, point mutations; vectors; host cells
10/27/2005US20050239059 67 human secreted proteins
10/27/2005US20050239055 Enterovirus primers and probes
10/27/2005US20050239052 Cloning of rhadinovirus genome and methods for its use
10/27/2005US20050238607 FGF-5 supported and binding peptides
10/27/2005DE10118043B4 Hochspezifisches Detektionssystem Highly specific detection system
10/27/2005CA2848463A1 Gene expression markers for predicting response to chemotherapy
10/27/2005CA2563388A1 Microrna and methods for inhibiting same
10/27/2005CA2563266A1 Kluyveromyces lactis promoter variants lacking e. coli transcriptional capability
10/27/2005CA2561742A1 Methods for identifying risk of osteoarthritis and treatments thereof
10/26/2005EP1589116A2 Use of an extraction control in a method of extracting nucleic acids
10/26/2005EP1589028A2 Modified oligonucleotides, their preparation and their use
10/26/2005EP1589025A2 Nucleic acid labeling compounds
10/26/2005EP1588761A2 Combinatorial strategies for polymer synthesis
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1588140A2 Cancer-associated nucleic acids and polypeptides
10/26/2005EP1588139A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor
10/26/2005EP1587923A2 Improved constructs for expressing lysosomal polypeptides
10/26/2005EP1587907A2 Kunitz domain library
10/26/2005EP1587843A2 Combinatorial libraries of monomer domains
10/26/2005EP1587816A2 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
10/26/2005EP1587815A2 Compounds and processes for single-pot attachment of a label to nucleic acid
10/26/2005EP1587481A2 Sensitive proteasome sensor constructs and methods for their design and use
10/26/2005EP1587412A2 Methods of detecting gene expression in normal and cancerous cells
10/26/2005EP1587405A2 Novel compositions and methods for cancer
10/26/2005EP1509540A4 Claudin polypeptides, polynucleotides, and methods of making and use thereof
10/26/2005EP1390541B1 Method for detecting gram-positive bacteria
10/26/2005EP1303529B1 Method and device for producing oligomers and arrays of oligomers and the use of said device
10/26/2005CN1688718A Methods and compositions for detecting targets
10/26/2005CN1688716A Methods to assess quality of microarrays
10/26/2005CN1688708A Gene sequence method for testing T cell propagation
10/26/2005CN1688693A Selection and isolation of living cells using mRNA-binding probes
10/26/2005CN1688206A Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
10/26/2005CN1224708C i (Neisseria meningitidis) antigens
10/26/2005CN1224627C Modified factor VIII
10/25/2005US6958390 Compositions and kits for herpes simplex virus type 1 and 2 nucleic acid detection
10/25/2005US6958320 Sel-12 related methods
10/25/2005US6958226 envelope protein; HIV-derived retroviral vector particle; gene therapy
10/25/2005US6958225 Reduction of nucleotide sequence complexity of sample; obtain sample, incubate with enzymes, fragment sequences, ligate adaptors, amplify and recover sequences
1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 899